Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Benign and malignant pleural mesothelioma.

K H Antman, J M Corson

    Clinics in Chest Medicine
    |March 1, 1985
    PubMed
    Summary

    Malignant mesothelioma, linked to asbestos exposure, is increasing despite predicted future declines. Early diagnosis and investigational therapies are crucial for managing this asbestos-related cancer.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Multipoint targeting of the PI3K/mTOR pathway in mesothelioma.

    British journal of cancer·2014
    Same author

    AXL regulates mesothelioma proliferation and invasiveness.

    Oncogene·2010
    Same author

    Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer.

    Bone marrow transplantation·2003
    Same author

    New biology and therapies in soft tissue sarcomas.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2002
    Same author

    Overview of the six available randomized trials of high-dose chemotherapy with blood or marrow transplant in breast cancer.

    Journal of the National Cancer Institute. Monographs·2002
    Same author

    Protocol for the examination of specimens from patients with tumors of the peritoneum: a basis for checklists.

    Archives of pathology & laboratory medicine·2001

    Area of Science:

    • Oncology
    • Epidemiology
    • Occupational Health

    Background:

    • Malignant mesothelioma, particularly pleural mesothelioma, is strongly associated with asbestos exposure.
    • While incidence is predicted to peak and decline due to past exposures, ongoing use of asbestos in products poses continued risk.
    • Construction workers and others maintaining or removing asbestos remain a high-risk group.

    Purpose of the Study:

    • To review the epidemiology, diagnosis, and treatment of malignant mesothelioma.
    • To highlight the continued relevance of asbestos exposure despite predicted incidence trends.
    • To advocate for investigational therapies in mesothelioma management.

    Main Methods:

    • Review of data from the Connecticut tumor registry.
    • Analysis of epidemiological models for mesothelioma incidence based on past asbestos exposure.
    • Discussion of diagnostic approaches, including biopsy and ancillary studies.
    • Overview of current and investigational treatment strategies.

    Main Results:

    • Mesothelioma incidence is increasing, with a predicted peak in the 1990s followed by a decline.
    • A safe threshold for asbestos exposure below which mesothelioma risk is eliminated has not been established.
    • Diagnosis typically involves chest pain, shortness of breath, and pleural effusion, requiring biopsy for confirmation.
    • Treatment remains challenging, though palliative care and a 30% response rate to chemotherapy have been reported.

    Conclusions:

    • Malignant mesothelioma, though rare, warrants consideration in differential diagnoses due to its asbestos link.
    • Despite challenges, investigational therapies should be offered to patients.
    • Continued vigilance regarding asbestos exposure and mesothelioma is necessary.

    Related Experiment Videos